This work is licensed under a Creative Commons Attribution 4.0 International License.
Quality of life assessment in penile cancer patients: A systematic review
Corresponding Author(s) : Cristian Antonio Pardo Munevar
Ciencia e Innovación en Salud,
Introduction: Cancer is one of the leading causes of disease in the world. Tumors of urological origin have a high impact on the morbidity and mortality of the population. Penile cancer constitutes 1% of neoplasms of the urinary system. The therapeutic strategies traditionally were based on improving survival, however, there is currently a tendency to improve also the physical, emotional and social aspect, understanding the disease as a process that affects the physical and mental; therefore, quality of life has been considered as an important clinical indicator, not only of well-being but also of the progression of the disease and the effectiveness of the treatment. Method: Search in the databases: MEDLINE® via Ovid; EMBASE; CENTRAL and LILACS. Subsequently, the articles found are evaluated, identifying eligibility criteria, this information was confirmed and verified by the researchers. Results: The search strategy established, identified 12 articles with five duplicates. Seven articles were evaluated, however, none of them met the inclusion criteria. Conclusions: In the literature review made, no studies were found that evaluated or validated scales of quality of life in patients with penile cancer. It is suggested to generate studies that validate specific scales for these patients; given the psychological implication that this type of cancer has for men.
Download CitationEndnote/Zotero/Mendeley (RIS)
- World cancer factsheet. 2014;2012(2012):2012–5.
- Medina-villaseñor EA, Ibáñez-garcía AO, Martínez-macías R, Barra- R, Quezada-adame I, Pérez-castro JA, et al. Carcinoma of the penis . Review of the clinicopathological characteristics. 2010;9:282–96. https://www.elsevier.es/es-revista-gaceta-mexicana-oncologia-305-articulo-cancer-pene-revision-caracteristicas-clinico-patologicas-X1665920110004344
- WHO. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–8.
- Group THEW. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. 1998;551–8.
- Lobo Heldwein F, Sánchez-Salas RE, Sánchez-Salas R, Teloken PE, Teloken C, Castillo O, et al. Salud y calidad de vida en urología: aspectos en urología general y oncológica. Arch Españoles Urol. 2009;62(7):519–30. http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0004-06142009000700001
- Fayers P, Bottomley a. Quality of life research within the EORTC—the EORTC QLQ-C30. Eur J Cancer. 2002;38:125–33. DOI: 10.1016/s0959-8049(01)00448-8
- Coates A, Porzsolt F, Osoba D. Quality of Life in Oncology Practice : Prognostic Value of EORTC QLQ-C30 Scores in Patients with Advanced Malignancy. Eur J Cancer. 1997;33(7):1025–30. DOI: 10.1016/s0959-8049(97)00049-x
- Moya M, Peñafiel M, Melo LP, Gonzalez G, Henriquez GJ. Cáncer de pene : patología infrecuente en la consulta Médica . “Reporte de dos Casos y Revisión Literaria”. 2016;22(2):109–12. http://www.scielo.org.co/scielo.php?pid=S0122-06672016000200010&script=sci_abstract&tlng=es
- Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD, et al. Validation and Reliability Testing of the EORTC QLQ-NMIBC24 Questionnaire Module to Assess Patient-reported Outcomes in Non – Muscle-invasive Bladder Cancer. Eur Urol. 2017;66(6):1148–56. DOI: 10.1016/j.eururo.2014.02.034
- Perlis N. Developing the Bladder Utility Symptom Scale : A Multiattribute Health State Classification System for Bladder Cancer by Developing the Bladder Utility Symptom Scale : A Multiattribute. University of Toronto; 2013. http://ihpme.utoronto.ca/document/developing-the-bladder-utility-symptoms-scale-a-multiattribute-health-state-classification-system-for-bladder-cancer/
- Zaharia M. El Cáncer Como Problema De Salud Pública En El Perú. Rev Peru Med Exp Salud Publica. 2013;30:7–8. http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342013000100001
- Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66(4):271–89. DOI: 10.3322/caac.21349